Lyrica Capsule
Pricing Report NDC 58151-241-77

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Lyrica (NDC 58151-241-77) is $9.69491 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a a human prescription drug provided by Viatris Specialty Llc, this medication is distributed in a 90 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$9.69491
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jun 17, 2026
Billable Units
90 EA
Estimated Package Price
$872.54
Data Status
As of Jul 08, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
58151-241-77
Description
90 CAPSULE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $0.05728 (Effective: Jun 17, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2025, the NADAC wholesale price for (NDC ) has moved within a range of $9.69491 to $9.70999 per EA. Over this 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$9.6949 - $9.7100
Market Volatility
0.16% Variance
Latest Trend
0.02%
Date Unit Price Unit Source Method Rate
Jun 17, 2026 $9.69491 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $9.69674 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $9.69617 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $9.70235 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $9.70183 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $9.70171 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $9.70175 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $9.70303 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $9.70999 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 30, 2025 $9.70600 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 30, 2025 $9.70600 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jul 30, 2025 $9.70600 EAC/I - Chain or Independent PharmacyCode 2B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026